Trademarkia Logo

Canada

C$
Trademark Search in Canada
QFITLIA

View On IC.GC.CA

QFITLIA
REGISTERED

on 29 Jul 2024

Last Applicant/ Owned by

GENZYME CORPORATION (A MASSACHUSETTS CORPORATION)

50 Binney StreetCambridge, Massachusetts 02142

US

Serial Number

2108894 filed on 21st May 2021

Registration Number

TMA1247414 registered on 29th Jul 2024

Registration expiry Date

29th Jul 2034

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

QFITLIA

Trademark usage description

pharmaceutical preparations for the treatment of autosomal dominant polycystic kidney disease; pharmaceutical preparations for the treatment of lysoso Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of autosomal dominant polycystic kidney disease; pharmaceutical preparations for the treatment of lysosomal storage diseases

Classification kind code

12

Mark Details

Serial Number

2108894

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 55
on 29th Jul 2024		Registered
Submitted for opposition 190
on 19th Jul 2024		Registration Pending
Submitted for opposition 42
on 1st May 2024		Advertised
Submitted for opposition 26
on 8th Apr 2024		Approved
Submitted for opposition 27
on 8th Apr 2024		Approval Notice Sent
Submitted for opposition 22
on 2th Apr 2024		Search Recorded
Submitted for opposition 287
on 5th Jul 2022		Pre-Assessment Letter Sent
Submitted for opposition 30
on 21st May 2021		Filed
Submitted for opposition 1
on 21st May 2021		Created
Submitted for opposition 31
on 21st May 2021		Formalized